Search companies

Live

EMYRIA LIMITED (ASX: EMD)

Health care · News and insights

Price unavailable

Latest EMD announcements

Announcement Insights

Emyria’s FY26 Revenue Rises 191% As Clinic Network Expands

Emyria reported FY26 revenue of approximately $4 million, up 191% from FY25, as its treatment network grew to five clinics and 18 beds. Its September-quarter update showed revenue of approximately $1 million, about double the same quarter a year earlier, and the opening of its first Sydney clinic; the company also reported initial Department of Veterans’ Affairs patient approvals and late-stage discussions with a pharmaceutical sponsor, with no agreement finalised.

Updated 12 Nov 2026, 05:53 PM Sydney time
Share
Sources2026 Annual General Meeting PresentationResults of Annual General MeetingNotification of cessation of securities - EMDSeptember 2026 Quarterly Investor Webinar PresentationSeptember 2026 Quarterly Investor Update Webinar InvitationSeptember 2026 Quarterly Activities Report and Appendix 4C
Comments

Emyria Shareholders Back Name Change And Placement Facility

2026-11-12 · Health care

EMD: $0.038 +2.70% · MC: $31M

Emyria shareholders passed all resolutions at the annual meeting, including approval of a company name change and a 10% placement facility. The accompanying presentation highlights FY26 revenue of $4 million, up 191% from FY25, alongside expansion to five clinics and 18 treatment beds.

Updated 2026-11-12 17:39
Share
Sources2026 Annual General Meeting PresentationResults of Annual General Meeting
Comments

Emyria Highlights 191% FY26 Revenue Growth As Clinic Network Reaches Four States

2026-11-02 · Health care

EMD: $0.040 +2.56% · MC: $31M

Emyria’s webinar presentation reports FY26 revenue of approximately $4 million, up 191%, and says its network now spans four states, with 18 treatment beds and more than 160 patients treated. The figures follow its September-quarter update, which reported record quarterly revenue of approximately $1 million and the opening of its first Sydney clinic.

Updated 2026-11-02 13:29
Share
SourcesSeptember 2026 Quarterly Investor Webinar Presentation
Comments

Emyria Sets Investor Webinar To Discuss Quarterly Update

2026-10-30 · Health care

EMD: $0.039 +0.00% · MC: $31M

Emyria will hold a webinar on 2 November, where its executive chairman and chief operating officer are scheduled to present a quarterly investor update. The invitation follows the company’s September-quarter report, which disclosed record quarterly revenue and the launch of its Sydney clinic.

Updated 2026-10-30 08:59
Share
SourcesSeptember 2026 Quarterly Investor Update Webinar Invitation
Comments

Emyria Revenue Triples As Sydney Clinic Opens And US Strategy Advances

2026-10-29 · Health care

EMD: $0.039 -4.88% · MC: $31M

Emyria reported record quarterly revenue of approximately $1 million, up from approximately $0.5 million in the same quarter last year, and opened its first Sydney clinic, expanding its network to four states with capacity for up to 90 dosing sessions a week. It received initial Department of Veterans’ Affairs patient approvals, with more than 40 referrals in its pipeline, and appointed former US Veterans Affairs Secretary Dr David Shulkin as a strategic adviser to support US opportunities. The company also said it is in late-stage discussions with an international pharmaceutical sponsor, but no agreement has been finalised.

Updated 2026-10-29 09:54
Share
SourcesSeptember 2026 Quarterly Activities Report and Appendix 4C
Comments